Navigation Links
Skin Flaps Deliver Cancer-fighting Therapy, ASPS Study Reveals
Date:5/8/2008

Treatment Provides "Blueprint" to Produce Therapeutic Proteins at Tumor Site

ARLINGTON HEIGHTS, Ill., May 8 /PRNewswire-USNewswire/ -- Using gene therapy, plastic surgeons have delivered cancer fighting proteins through skin flaps placed on cancerous tumors on rats with a 79 percent reduction in tumor volume, according to a study in the May issue of Plastic and Reconstructive Surgery(R), the official medical journal of the American Society of Plastic Surgeons (ASPS). This new delivery technique, which has yet to be tested in humans, did not cause toxicity in the body of rats; however, administering the same anti-tumor agent intravenously in humans has previously been shown to cause liver damage.

"This new technique may allow us to reprogram skin flaps, using gene therapy, to provide a blueprint for anti-tumor agents like Interleukin-12 to be produced in the tumor to kill cancer, while avoiding adverse side effects," said Geoffrey Gurtner, MD, ASPS Member and study senior author. "In this study we took skin flaps in animal models and delivered IL-12 directly to the tumor area with tremendous success. Since skin flaps are used thousands of times each year in cancer patients, this may potentially open up an entirely new area in plastic surgery and bring the specialty, once again, to the center of medicine."

Gene therapy has been heralded as a new tool to restrain or prevent tumor growth and recurrence in humans, but its use has been limited because of serious side effects and the difficulty in concentrating anti-tumor agents at the site of the cancer.

In the study, skin flaps (a mass of healthy tissue) taken from rats were injected with the gene for IL-12 into the flaps' blood supply. The flaps were then placed onto cancerous tumors on the rats.

The study found a 79 percent reduction in tumor volume for animals treated with IL-12 compared to control animals. The treatment allowed individual cells within the flap to be
'/>"/>

SOURCE American Society of Plastic Surgeons
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
2. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
3. New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients
4. Intradigm Study Shows Ability of siRNAs Systemically Delivered With TargeTran(TM) System to Suppress Tumor-Induced Angiogenesis in Mice
5. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
6. Dr. Rajeev Venkayya Joins Gates Foundation as Director of Global Health Delivery
7. Study Shows Intradigms RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models
8. Micromet Shows Feasibility of Subcutaneous Delivery of BiTE Antibody in Preclinical Primate Study
9. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
10. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
11. PARIs eFlow Delivers Alnylam RNAi Therapeutic in Phase II Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)... Potential New Approach for the Treatment of Infla...lestone Triggers $10 Million Payment from Partner ...RNewswire/ -- ChemoCentryx, Inc., today,announced ...54, an,orally-available, novel small molecule comp...okine receptor which is associated with inflammato...
(Date:5/12/2008)...NCISCO, Calif., May 12 /- N...nnounces that it presented a,poster in collaborati...ment,of a patient reported outcomes questionnaire ...QoL) aspects of chronic diarrhea in persons living...or Pharmacoeconomics and,Outcomes Research (ISPOR)...
(Date:5/12/2008)...opens way for high-power permanent version of the ...udy, BOSTON, May 12 /- Innovative pr...nd the daily lives of patients with,hemianopia, a ...h eyes. The,peripheral prism glasses, which were i...epens Eye Research Institute, were evaluated in th...
(Date:5/12/2008)...adjust their function like a radio dial, not an on...utoimmune disease may develop,late in life, MEM...t. Jude Children,s,Research Hospital study shows t...do not use simple on/off switches to govern the ce...and function. Rather, they,possess sophisticated m...
Breaking Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Napo Presents at ISPOR Meeting in Toronto 2Prism Glasses Expand the View for Patients with Hemianopia 2Prism Glasses Expand the View for Patients with Hemianopia 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 2St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 3St. Jude Study Shows How T Cell's Machinery Dials Down Autoimmunity 4European lead in reading past climates from ice cores 759 1European lead in reading past climates from ice cores 759 2European lead in reading past climates from ice cores 759 3ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 1ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 2ReBuilder Medical Technologies Inc Announces Agreement with Internet Marketer Helio Health 3B Anticipates 12 25 Additional Profit 3466 3CVS pharmacy to Remove OTC Infant Cough 26 Cold Products from Its Stores as Part of CHPAs Voluntary Withdrawal 3463 1CVS pharmacy to Remove OTC Infant Cough 26 Cold Products from Its Stores as Part of CHPAs Voluntary Withdrawal 3463 2Yoplait 28R 29 Challenges One Million Americans to Pledge to Their Breast Health 3460 1Yoplait 28R 29 Challenges One Million Americans to Pledge to Their Breast Health 3460 2Yoplait 28R 29 Challenges One Million Americans to Pledge to Their Breast Health 3460 3
...herapeutics,Inc., a specialty pharmaceutical comp...ry and infectious diseases, today announced,the co...scana,– a topical formulation designed to tr...rimary end point and demonstrated statistical,sign...atient,population. Typically, a probability value...
...s and upcoming,milestones on its insulin program -...SemBioSys,Genetics Inc. , a biotechnology company ... metabolic and cardiovascular disease,today annou...lopment of plant-derived recombinant human insulin...cientific Sessions of the,American Diabetes Associ...
Other Medicine Technology:MediQuest Concludes Confirmatory Phase III Study of Raynaud’s,Therapy 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 2SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 3SemBioSys Presents Positive Insulin Data at the American Diabetes,Association Conference 4
(Date:5/13/2008)... HARBIN, China, May 13 /Xinhua-PRNewswire-FirstCa...oard: CSKI), a manufacturer, marketer and,distribu...oducts in China,today announced that it will cond... May 15, 2008 to discuss its first quarter 2008 fi...man, CEO and Director of China Sky One,Medical, In...
(Date:5/13/2008)...ildbearing had no such benefit if baby was bottle-...13 (HealthDay News) -- Women who breast feed for m...arthritis (RA) by half, according to a new Swedish...g children but not breast-feeding offered women no...contraceptives also failed to reduce the risk of R...
(Date:5/13/2008)...NEW YORK (May 13, 2008) -- Promising results from ...ell Medical Center physician-scientists show that ... the progression of Batten disease, or Late Infant..., genetic, degenerative neurological disorder that... to 12. , The clinical trial found that the pro...
(Date:5/13/2008)... SALT LAKE CITY, May 13 /PRNewswire/ -- Paramed S...ent of their marine-grade Mobility Offers,Versatil...chair to oil and,gas platform operators in the Gul...platforms will enable the safe and timely evacuati...atform., Paramed developed the dual-track MOV in ...
Breaking Medicine News(10 mins):Health News:China Sky One Medical, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Breast-feeding Might Shield Women From Rheumatoid Arthritis 2Health News:NYP/Weill Cornell gene therapy clinical trial yields promising results for Batten disease 2
... tissue abnormalities, or lesions, that typically ...nfected with multiple genotypes// of the human pap...ing to a study published in the July issue of Canc...ion. Although doctors have known that the cervica...
...ter is among 10 institutions selected to oversee i...ving interventions for critical trauma// and sudde...th has joined with other U.S. and Canadian agencie...on Outcomes Consortium (ROC) and establish federal...
...ttle super bugs, including MRSA, has found its way...d the news as Tygacil, is one of the few new antib...rs. Micro organisms have undergone mutations that...sistance to the existing antibiotics, leading to w...
...sleep would probably help the human brain to enhan...arned facts.// It was reported that previous stud...declarative memories, like the steps of learning t... It was explained that the new experiment focuses ...
Other Medicine News:Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 2Health News:Higher Risk for Cervical Cancer Seen Among Women Infected with Multiple HPV Types 3Health News:Medical Center to Test Methods of Improving Cardiac Arrest, Trauma Survival 2Health News:New Drugs To Combat Mutant Bugs 2Health News:Sleep Essential For A Strong Memory 2
...sists of a sterile Hemostatic Dressing supplied to...,Both devices work together to promote dual-action...cal hemostasis by facilitating clotting at the ski...tem provides external compression to facilitate cl...
The ALLEGRO Analyzer has been specifically designed to deliver wavefront data needed to perform safe and successful wavefront guided laser vision correction. All components such as the user interface
Absolute precision demands absolute knowledge. Access it with the Bausch & Lomb Zyoptix Diagnostic Workstation, uniting two trusted technologies: Zywave II Wavefront Aberrometer and Orbscan IIz Anter
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e
Medicine Products: